In line with the proposed mechanism, immunofluorescence analysis demonstrated a marked upregulation of ATF3 expression in tumor tissues from Vin-treated mice (Fig. S8B), supporting the in vivo activation of the P38/MAPK/ATF3 signaling pathway and its role in mediating IL-24 expression. The gene discussed is ATF3; the disease is neoplasm.